These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 4200529)
1. A controlled study of the clinical effects of amantadine hydrochloride (Symmetrel). Merrick EM; Schmitt PP Curr Ther Res Clin Exp; 1973 Aug; 15(8):552-8. PubMed ID: 4200529 [No Abstract] [Full Text] [Related]
2. Amantadine in drug-induced extrapyramidal signs: a comparative study. Ananth J; Sangani H; Noonan JP Int J Clin Pharmacol Biopharm; 1975 Jun; 11(4):323-6. PubMed ID: 239908 [TBL] [Abstract][Full Text] [Related]
3. A double-blind study of amantadine hydrochloride versus benztropine mesylate in drug-induced parkinsonism. Kelly JT; Zimmermann RL; Abuzzahab FS; Schiele BC Pharmacology; 1974; 12(2):65-73. PubMed ID: 4610599 [No Abstract] [Full Text] [Related]
4. Amantadine HCL (Symmetrel) and its relation to Levo-Dopa in the treatment of Parkinson's disease. Schwab RS; England AC Trans Am Neurol Assoc; 1969; 94():85-90. PubMed ID: 4907453 [No Abstract] [Full Text] [Related]
5. Controlled trial of amantadine hydrochloride in Parkinson's disease. Jorgensen PB; Bergin JD; Haas L; Cuningham JA; Morah DD; Pollock M; Robinson RG; Spears GF N Z Med J; 1971 May; 73(468):263-7. PubMed ID: 4932146 [No Abstract] [Full Text] [Related]
6. Comparison of benztropine mesylate and amantadine HCl in neuroleptic-induced extrapyramidal symptoms. Stenson RL; Donion PT; Meyer JE Compr Psychiatry; 1976; 17(6):763-8. PubMed ID: 791573 [No Abstract] [Full Text] [Related]
7. A controlled trial of amantadine in drug-induced extrapyramidal disorders. DiMascio A; Bernardo DL; Greenblatt DJ; Marder JE Psychopharmacol Bull; 1977 Jul; 13(3):31-3. PubMed ID: 18755 [No Abstract] [Full Text] [Related]
8. Amantadine hydrochloride in the treatment of Parkinsonism. A controlled trial. Appleton DB; Eadie MJ; Sutherland JM Med J Aust; 1970 Oct; 2(14):626-9. PubMed ID: 4920572 [No Abstract] [Full Text] [Related]
9. Double blind study using amantadine hydrochloride in the therapy of Parkinson's disease. Silver DE; Sahs AL Trans Am Neurol Assoc; 1971; 96():307-8. PubMed ID: 4945919 [No Abstract] [Full Text] [Related]
10. [Iron, transferrin, copper and ceruloplasmin of the serum and cerebrospinal fluid in extrapyramidal diseases and primary myopathies. Study in basic conditions and in Parkinsonism after treatment with dopaminergic agents (L-dopa, L-dopa + RO 4-4602, amantadine)]. Campanella G; Carrieri P; Romito D; Pasqual-Marsettin E Acta Neurol (Napoli); 1973; 28(1):1-34. PubMed ID: 4704396 [No Abstract] [Full Text] [Related]
11. [Treatment of the Parkinson syndrome with amantadine]. Hartmann-von Monakow K Schweiz Med Wochenschr; 1971 Dec; 101(48):1736-9. PubMed ID: 5140093 [No Abstract] [Full Text] [Related]
12. [Experimental design of a pilot study on amantadine in the extrapyramidal syndrome induced by neuroleptic drugs]. Ferrari P; Robotti E; Nardini M Boll Chim Farm; 1972 Oct; 111(10):610-5. PubMed ID: 4566407 [No Abstract] [Full Text] [Related]
13. [The additive effect of amantadine hydrochloride (Symmetrel) on parkinsonian patients receiving levodopa treatment (author's transl)]. Shiozawa R; Kase M; Kuroiwa Y; Narabayashi H; Nishitani Y; Ohmoto T; Toyokura Y; Uono K No To Shinkei; 1981 Mar; 33(3):301-9. PubMed ID: 7018522 [No Abstract] [Full Text] [Related]